Screening method for congenital dysfibrinogenemia using clot waveform analysis with the Clauss method.
Shinpei AraiTomu KamijoFumiaki HayashiSho ShinoharaNobuo AraiMitsutoshi SuganoTakeshi UeharaTakayuki HondaNobuo OkumuraPublished in: International journal of laboratory hematology (2020)
This report demonstrates that CWA parameters of the Clauss method, Clauss/dH plus Clauss/Min1 ratio, screened Dys patients with a higher rate, whereas Clauss/PT-derived ratios did not.
Keyphrases